Bir Dawn Carter Insider Trades

Insider Trading History

Track insider trading activity for Bir Dawn Carter. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Geron
Geron GERN
Director
Holding Value $266k 220,000 shares
Last Trade
May 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$277k 220,000 shares
$1.26
$1.21
Soleno Therapeutics
Soleno Therapeutics SLNO
Director
Holding Value $0 0 shares
Last Trade
May 18, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$901k 16,991 shares
$53.01
$53.01
Cassava Sciences
Cassava Sciences SAVA
Director
Holding Value $70k 53,000 shares
Last Trade
Oct 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$211k 53,000 shares
$3.98
$1.32
Soleno Therapeutics
Soleno Therapeutics SLNO
Director
Holding Value $901k 16,991 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 3,991 shares
$75.22
$53.01
Geron
Geron GERN
Interim President And CEO
Holding Value $218k 180,000 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$241k 180,000 shares
$1.34
$1.21
Soleno Therapeutics
Soleno Therapeutics SLNO
Director
Holding Value $689k 13,000 shares
Last Trade
Aug 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$656k 13,000 shares
$50.46
$53.01
Geron
Geron GERN
Director
Holding Value $218k 180,000 shares
Last Trade
May 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$698k 180,000 shares
$3.88
$1.21
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Sep 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$51.1M 296,505 shares
$172.36
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Commercial Officer
Holding Value $5.83M 33,805 shares
Last Trade
Aug 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$67k 398 shares
$168.33
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Commercial Officer
Holding Value $5.9M 34,203 shares
Last Trade
Aug 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$136k 807 shares
$169.04
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Commercial Officer
Holding Value $12.9M 75,010 shares
Last Trade
Jul 28, 2023 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$6.69M 40,000 shares
$167.19
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Jul 28, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.69M 40,000 shares
$167.19
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Jul 28, 2023 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$6.69M 40,000 shares
$167.19
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Commercial Officer
Holding Value $6.03M 35,010 shares
Last Trade
Jul 28, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.58M 40,000 shares
$164.54
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Commercial Officer
Holding Value $6.89M 40,000 shares
Last Trade
Jul 28, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.69M 40,000 shares
$167.19
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Commercial Officer
Holding Value $6.03M 35,010 shares
Last Trade
Jul 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 4,125 shares
$107.89
$172.36
Geron
Geron GERN
Director
Holding Value $151k 125,000 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$409k 125,000 shares
$3.27
$1.21
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Commercial Officer
Holding Value $5.32M 30,885 shares
Last Trade
May 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$33.8k 417 shares
$80.96
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Commercial Officer
Holding Value $5.4M 31,302 shares
Last Trade
May 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$76.1k 894 shares
$85.09
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Commercial Officer
Holding Value $5.55M 32,196 shares
Last Trade
Mar 13, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$808k 9,317 shares
$86.77
$172.36

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up